Movianto Bedford

Movianto UK put into operation a new GMP-certified rework facility in Bedford

 

Press release, 7th January 2025

 

Movianto UK put into operation a new GMP-certified rework facility in Bedford

 

•  Specialist for healthcare logistics increases capacity for secondary packaging services

Movianto Bedford GMP certified facility(Bedford/UK) Movianto UK has put into operation a new GMP-certified rework facility at its UK centre of logistics operations in Bedford. ‘Market demand for secondary packaging in the pharmaceutical and healthcare industries is continuously increasing, more and more companies recognise the benefits of not bringing back products to their own manufacturing or rework facility for changes in secondary packaging’, says David Evans, Managing Director of Movianto UK. The company is a part of the Walden Group, a leading European healthcare supply chain solutions partner specialising in pharmaceutical, biotech, and medical device logistics. ‘Instead of transporting the items back to other countries or even into other continents, they save time, money, carbon emission, and employee hours by giving them to our dedicated team in the UK where the goods are already in storage.’

Integral to this operation is a GMP licence. Movianto UK has more than eleven years of experience in the licensed secondary packaging and reworking of pharmaceutical products or medical devices but having moved into a new site at Bedford in 2023, the accreditation had to be renewed. Now, in an enlarged GMP-rework room, specially trained Movianto employees have the ability to insert new patient information leaflets, adjust expiry dates due to new regulations, replace damaged outer packaging, machine wrap multiple packs, tamper evident sealing and more.

GMP, which in the context of pharma logistics stands for Good Manufacturing Practice, refers to a set of guidelines and regulations that ensure the consistent production and control of pharmaceutical products according to proven and audited quality standards. The employees working under the licence must strictly adhere to the processes laid out by Movianto’s Qualified Person. GMP guidelines cover various aspects of pharmaceutical handling, including temperature control, hygiene standards, and seamless documentation. These procedures minimise risks involved in pharmaceutical production and distribution, ensuring that products are safe, effective, and of consistent quality.

About Movianto

Since 2020, Movianto is a part of the Walden Group. With its one-stop-shop service for the distribution of healthcare products, Walden is today Europe’s market leader for logistics and transport in the pharmaceutical and healthcare industry. Movianto strives to be the preferred European logistics partner for this industry and to provide the best service for pharmaceutical and biotech products, medical devices, and diagnostics. As an outsourcing partner along the logistics chain for such products, Movianto offers temperature-controlled warehouse logistics and transport, as well as complete solutions such as order to cash or purchasing and procurement services. Movianto’s international customers benefit from a Europe-wide network, a broad range of pharmaceutical logistics services, unique industry expertise, and standardised processes in accordance with quality standards such as ISO 9001 and ISO 13485. Movianto employs more than 3,700 people, has over 600,000 pallet spaces in its network of 23 own logistics centres in twelve European countries and operates throughout Europe. www.movianto.com

 

About Walden

Founded in 1951 in the center of France, Walden Group is a family-owned company, Europe’s leader in healthcare supply chain solutions. The group offers end-to-end services for every stage of the pharmaceutical supply chain: from classic logistics to innovative value-added services (order to cash, secondary packaging, serialization, etc.). Within the group, each business unit specialises in key areas of the supply chain: Transpharma International in first-mile transport and shipping, Movianto in logistics and value-added services, and Eurotranspharma in last-mile solutions.

The group’s growth, with a turnover of €2.9 billion in 2023, is driven by a strong ability to adapt to the market in which it operates, especially by investing in new infrastructure, automation and digital tools. Thanks to an ambitious external growth strategy, the group is now present in 15 countries (France, Spain, Germany, Italy, the Netherlands, Belgium, Denmark, England, Ireland, Switzerland, Morocco, Poland, the Czech Republic, Slovakia, Romania and India). Walden Group employs more than 6,000 people at more than 250 sites and nearly one million m² of warehouses.


Contact for press enquiries:

David Evans                                              Ludwig-Michael Cremer
MD Movianto UK                                      external press office Movianto
Tel +44 7780 270526                                Tel +49 7071 640 315
press@movianto.com                              team@log-pr.de